Journal
HORMONE RESEARCH
Volume 60, Issue 6, Pages 297-301Publisher
KARGER
DOI: 10.1159/000074248
Keywords
alstrom syndrome; growth hormone; insulin resistance; acanthosis nigricans
Categories
Ask authors/readers for more resources
Aim: To investigate the metabolic effects of recombinant human growth hormone ( rhGH) in an Alstrom syndrome patient with growth hormone deficiency. Methods: A 15-year- old Alstrom syndrome boy with growth hormone deficiency received rhGH therapy for 1 year. Biochemical parameters, including hepatic enzyme levels, lipid profiles, and insulin sensitivity, were measured. Body composition analysis and computed tomography scans of the liver were performed. Results: After 1 year of rhGH treatment, body fat mass, fat infiltration in the liver, and serum lipid profiles had all decreased. Insulin sensitivity and acanthosis nigricans improved. Conclusion: rhGH therapy might have beneficial effects on body composition, liver fat content, lipid profiles, and insulin resistance in Alstrom syndrome patients, with improvement of the glucose homeostasis. Copyright (C) 2003 S. Karger AG, Basel.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available